Rock Springs Capital Management LP
CIK 1595725 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $2.0B
- Posisi
- 104
- Per tanggal
- 30 Juni 2026
#1.491 dari 9.443 berdasarkan nilai 13F · top 15.8%
Nilai portofolio QoQ: +20.8% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 43,96%
- Bobot 25 kepemilikan teratas
- 65,65%
- Posisi di atas 1%
- 32
- Jumlah posisi efektif
- 32,7
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 13,68% Perkiraan pembelian $256.139.663 · penjualan $263.128.657
Kepemilikan median: 4,0 kuartal Dilacak Q4 2024–Q2 2026 · 59,8% masih dipegang
- Posisi baru
- 17
- Meningkat
- 40
- Menurun
- 30
- Tertutup
- 13
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
- Terkait Orang di balik pengaju ini, jika kami dapat mencocokkannya.
Kinerja vs S&P 500
Tahunan: +34.8% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 96,1% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
91,7%
Lainnya/Tidak terpetakan
8,3%
Portofolio lengkap 104 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. - Common Stock | $206.983.729 | 10,10% | 1.105.210 | $89.363.258 | Turun ×2 | ||
| TVTX Travere Therapeutics, Inc. - Common Stock | $123.792.910 | 6,04% | 2.179.069 | $79.882.897 | Naik ×1 | ||
| LLY Eli Lilly and Company Common Stock | $118.383.741 | 5,78% | 98.700 | $27.602.442 | |||
| MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | $93.965.713 | 4,59% | 174.999 | $4.452.866 | Naik ×3 | ||
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $93.438.835 | 4,56% | 798.145 | $18.491.495 | Turun ×1 | ||
| RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | $76.899.156 | 3,75% | 692.598 | $16.911.772 | Naik ×1 | ||
| KYMR Kymera Therapeutics, Inc. - Common Stock | $51.963.399 | 2,54% | 453.156 | $10.579.013 | Turun ×1 | ||
| ARGX argenx SE - American Depositary Shares | $48.939.868 | 2,39% | 52.750 | $-22.989.757 | Turun ×4 | ||
| Penerbit tidak dikenal (CUSIP: K08588103) | $45.009.000 | 2,20% | 168.750 | Naik ×1 | |||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $41.280.627 | 2,01% | 683.907 | $-3.088.986 | Turun ×4 | ||
| SRRK Scholar Rock Holding Corporation - Common Stock | $39.349.860 | 1,92% | 715.452 | $2.980.505 | Turun ×1 | ||
| INSM Insmed Incorporated - Common Stock | $38.612.433 | 1,88% | 362.150 | $-12.781.903 | Naik ×1 | ||
| PEN Penumbra, Inc. Common Stock | $36.548.063 | 1,78% | 115.750 | $-3.020.522 | Turun ×1 | ||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $34.365.813 | 1,68% | 640.317 | $3.507.354 | Naik ×1 | ||
| RARE Ultragenyx Pharmaceutical Inc. - Common Stock | $32.316.678 | 1,58% | 967.855 | $6.783.384 | Turun ×2 | ||
| IRTC iRhythm Holdings, Inc. - Common Stock | $32.074.868 | 1,57% | 269.650 | $1.183.133 | Naik ×2 | ||
| ISRG Intuitive Surgical, Inc. - Common Stock | $30.406.613 | 1,48% | 76.460 | $-7.394.567 | Turun ×1 | ||
| Penerbit tidak dikenal (CUSIP: 00857U206) | $28.145.468 | 1,37% | 262.600 | $26.088.868 | Naik ×1 | ||
| UNH UnitedHealth Group Incorporated Common Stock (DE) | $26.496.413 | 1,29% | 63.750 | $12.155.143 | Naik ×2 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $26.015.223 | 1,27% | 699.146 | $5.388.659 | Naik ×1 | ||
| ERAS Erasca, Inc. - Common Stock | $25.687.388 | 1,25% | 1.402.150 | $7.833.260 | Naik ×2 | ||
| NBIX Neurocrine Biosciences, Inc. - Common Stock | $24.395.441 | 1,19% | 144.750 | $4.575.158 | Turun ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $23.579.719 | 1,15% | 464.625 | $-8.819.081 | Turun ×1 | ||
| THC Tenet Healthcare Corporation Common Stock | $23.385.000 | 1,14% | 125.000 | $-203.750 | |||
| DXCM DexCom, Inc. - Common Stock | $23.101.050 | 1,13% | 343.000 | $769.370 | Turun ×1 | ||
| ACRS Aclaris Therapeutics, Inc. - Common Stock | $22.908.514 | 1,12% | 4.330.532 | $6.136.076 | Turun ×1 | ||
| Penerbit tidak dikenal (CUSIP: 60365F109) | $22.724.000 | 1,11% | 1.520.000 | $6.983.400 | Naik ×1 | ||
| BSX Boston Scientific Corporation Common Stock | $22.556.380 | 1,10% | 528.500 | $-9.778.695 | Naik ×5 | ||
| PHVS Pharvaris N.V. - Ordinary Shares | $22.419.355 | 1,09% | 648.333 | $4.183.048 | Naik ×2 | ||
| Penerbit tidak dikenal (CUSIP: 05348Y105) | $21.823.261 | 1,07% | 662.918 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 423494103) | $21.135.617 | 1,03% | 575.432 | Naik ×1 | |||
| DYN Dyne Therapeutics, Inc. - Common Stock | $20.925.240 | 1,02% | 942.154 | $3.299.290 | Turun ×1 | ||
| ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | $20.093.753 | 0,98% | 66.750 | $-4.390.627 | Turun ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $19.965.988 | 0,97% | 515.917 | $-4.057.738 | Turun ×3 | ||
| AGIO Agios Pharmaceuticals, Inc. - Common Stock | $19.763.413 | 0,96% | 532.563 | $-7.272.271 | Turun ×1 | ||
| NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | $19.749.194 | 0,96% | 582.744 | $901.898 | Turun ×1 | ||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $18.347.629 | 0,90% | 427.584 | $-1.911.596 | Turun ×3 | ||
| TARS Tarsus Pharmaceuticals, Inc. - Common Stock | $17.439.856 | 0,85% | 277.087 | $1.643.549 | Naik ×1 | ||
| HTFL Heartflow, Inc. - Common Stock | $16.826.490 | 0,82% | 573.500 | $2.897.565 | Naik ×3 | ||
| MBX MBX Biosciences, Inc. - Common Stock | $16.461.634 | 0,80% | 298.218 | $7.865.819 | Naik ×2 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $16.014.016 | 0,78% | 187.980 | $13.024.075 | Naik ×2 | ||
| BCAX Bicara Therapeutics Inc. - Common Stock | $15.892.641 | 0,78% | 535.286 | $6.164.541 | Naik ×4 | ||
| Penerbit tidak dikenal (CUSIP: 698955101) | $15.820.626 | 0,77% | 578.028 | Naik ×1 | |||
| ZLAB Zai Lab Limited - American Depositary Shares | $15.479.433 | 0,76% | 814.707 | $154.794 | |||
| DHR Danaher Corporation Common Stock | $14.533.624 | 0,71% | 76.300 | $2.873.224 | Naik ×1 | ||
| TNGX Tango Therapeutics, Inc. - Common Stock | $14.271.784 | 0,70% | 456.551 | $6.177.522 | Naik ×1 | ||
| EVH Evolent Health, Inc Class A Common Stock | $13.550.000 | 0,66% | 2.500.000 | $7.451.000 | Turun ×1 | ||
| PTCT PTC Therapeutics, Inc. - Common Stock | $13.238.648 | 0,65% | 162.298 | $2.215.350 | Naik ×2 | ||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $13.083.978 | 0,64% | 484.951 | $1.171.123 | Naik ×5 | ||
| ZBIO Zenas BioPharma, Inc. - Common Stock | $12.742.714 | 0,62% | 502.077 | $2.927.109 | |||
| ARDX Ardelyx, Inc. - Common Stock | $11.433.022 | 0,56% | 2.241.769 | $-2.340.821 | Turun ×1 | ||
| INSP Inspire Medical Systems, Inc. Common Stock | $10.884.840 | 0,53% | 244.000 | $4.086.596 | Naik ×5 | ||
| BBIO BridgeBio Pharma, Inc. - Common Stock | $10.780.980 | 0,53% | 144.750 | $1.257.135 | Naik ×3 | ||
| ALKS Alkermes plc - Ordinary Shares | $10.469.097 | 0,51% | 199.811 | $3.963.352 | Naik ×3 | ||
| SMMT Summit Therapeutics Inc. - Common Stock | $10.417.550 | 0,51% | 715.000 | $-3.044.050 | Naik ×1 | ||
| AZTA Azenta, Inc. - Common Stock | $10.284.560 | 0,50% | 403.000 | $-1.740.523 | Turun ×1 | ||
| INDV Indivior Pharmaceuticals, Inc. - Common Stock | $10.072.865 | 0,49% | 245.500 | $3.976.865 | Naik ×1 | ||
| SYK Stryker Corporation Common Stock | $9.130.360 | 0,45% | 29.000 | $4.267.228 | Naik ×1 | ||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $8.975.761 | 0,44% | 499.764 | $2.029.041 | |||
| CAI Caris Life Sciences, Inc. - Common Stock | $8.687.250 | 0,42% | 487.500 | $-1.379.190 | Turun ×3 | ||
| OMDA Omada Health, Inc. - Common Stock | $8.187.350 | 0,40% | 373.000 | $1.386.980 | Turun ×4 | ||
| CMPX Compass Therapeutics, Inc. - Common Stock | $7.719.595 | 0,38% | 3.524.929 | $-9.765.484 | Naik ×1 | ||
| IMNM Immunome, Inc. - Common Stock | $7.367.043 | 0,36% | 347.666 | $-236.412 | |||
| EDAP EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share | $7.179.480 | 0,35% | 1.386.000 | $2.053.320 | Naik ×3 | ||
| PHR Phreesia, Inc. Common Stock | $7.171.101 | 0,35% | 696.900 | $2.139.749 | Naik ×1 | ||
| OMER Omeros Corporation - Common Stock | $6.832.925 | 0,33% | 718.499 | Naik ×1 | |||
| DFTX Definium Therapeutics, Inc. - Common Shares | $6.735.516 | 0,33% | 143.187 | Naik ×1 | |||
| CORT Corcept Therapeutics Incorporated - Common Stock | $6.260.400 | 0,31% | 72.000 | $4.234.822 | Naik ×1 | ||
| JANX Janux Therapeutics, Inc. - Common Stock | $5.637.258 | 0,28% | 367.009 | $535.833 | |||
| Penerbit tidak dikenal (CUSIP: 60705V103) | $5.603.880 | 0,27% | 418.200 | Naik ×1 | |||
| RCUS Arcus Biosciences, Inc. Common Stock | $5.549.400 | 0,27% | 180.000 | $1.661.400 | |||
| TMO Thermo Fisher Scientific Inc Common Stock | $5.013.600 | 0,24% | 10.000 | $98.300 | |||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $4.849.000 | 0,24% | 260.000 | Naik ×1 | |||
| SION Sionna Therapeutics, Inc. - Common Stock | $4.373.882 | 0,21% | 99.429 | $387.773 | |||
| CVS CVS Health Corporation Common Stock | $4.138.000 | 0,20% | 40.000 | $1.265.200 | |||
| EYPT EyePoint, Inc. - Common Stock | $3.839.822 | 0,19% | 268.519 | $504.676 | Naik ×1 | ||
| OCUL Ocular Therapeutix, Inc. - Common Stock | $3.768.091 | 0,18% | 383.716 | $518.016 | |||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $3.751.310 | 0,18% | 42.254 | Naik ×1 | |||
| TLPH Talphera, Inc. - Common Stock | $3.696.862 | 0,18% | 3.589.186 | $1.016.099 | |||
| ROIV Roivant Sciences Ltd. - Common Shares | $3.574.390 | 0,17% | 101.000 | $887.490 | Naik ×2 | ||
| PCVX Vaxcyte, Inc. - Common Stock | $3.502.333 | 0,17% | 60.250 | $1.205 | |||
| NGNE Neurogene Inc. - Common Stock | $3.357.288 | 0,16% | 106.750 | $1.253.814 | Naik ×1 | ||
| IPSC Century Therapeutics, Inc. - Common Stock | $3.195.650 | 0,16% | 1.304.347 | $247.826 | |||
| ATEC Alphatec Holdings, Inc. - Common Stock | $3.114.000 | 0,15% | 360.000 | $-694.000 | Naik ×2 | ||
| NVO Novo Nordisk A/S Common Stock | $3.044.190 | 0,15% | 63.500 | $-263.310 | Turun ×1 | ||
| OLMA Olema Pharmaceuticals, Inc. - Common Stock | $2.942.077 | 0,14% | 235.178 | $401.741 | Naik ×2 | ||
| NGEN NervGen Pharma Corp. - Common stock | $2.488.956 | 0,12% | 1.208.231 | Naik ×1 | |||
| MDT Medtronic plc. Ordinary Shares | $2.417.307 | 0,12% | 30.900 | Naik ×1 | |||
| TEVA Teva Pharmaceutical Industries Limited American Depositary Shares | $1.998.920 | 0,10% | 59.000 | $628.460 | Naik ×1 | ||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $1.981.378 | 0,10% | 20.326 | $-264.069 | Turun ×1 | ||
| SGMT Sagimet Biosciences Inc. - Series A Common Stock | $1.932.500 | 0,09% | 250.000 | ||||
| CAPR Capricor Therapeutics, Inc. - Common Stock | $1.792.708 | 0,09% | 74.448 | Naik ×1 | |||
| LENZ LENZ Therapeutics, Inc. - Common Stock | $1.462.373 | 0,07% | 257.460 | $-893.386 | |||
| ALT Altimmune, Inc. - Common Stock | $1.433.254 | 0,07% | 471.465 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 482931102) | $1.431.950 | 0,07% | 65.000 | Naik ×1 | |||
| SGRY Surgery Partners, Inc. - Common Stock | $1.411.200 | 0,07% | 84.000 | $-1.068.160 | Turun ×2 | ||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $1.346.235 | 0,07% | 5.500 | Naik ×1 | |||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $1.146.894 | 0,06% | 12.051 | $944.661 | Naik ×1 | ||
| VKTX Viking Therapeutics, Inc. - Common Stock | $994.755 | 0,05% | 25.500 | $-2.129.085 | Turun ×1 | ||
| LEGN Legend Biotech Corporation - American Depositary Shares | $967.480 | 0,05% | 33.500 | $234.835 | Turun ×1 | ||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
| Sekuritas | Nilai | % dari portofolio | Rentetan |
|---|---|---|---|
| MDGL | $93.965.713 | 4,59% | naik ×3 |
| BSX | $22.556.380 | 1,10% | naik ×5 |
| HTFL | $16.826.490 | 0,82% | naik ×3 |
| BCAX | $15.892.641 | 0,78% | naik ×4 |
| MLYS | $13.083.978 | 0,64% | naik ×5 |
| INSP | $10.884.840 | 0,53% | naik ×5 |
| BBIO | $10.780.980 | 0,53% | naik ×3 |
| ALKS | $10.469.097 | 0,51% | naik ×3 |
| EDAP | $7.179.480 | 0,35% | naik ×3 |
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| Penerbit tidak dikenal (CUSIP: K08588103) | $45.009.000 | 168.750 | 2,20% |
| Penerbit tidak dikenal (CUSIP: 05348Y105) | $21.823.261 | 662.918 | 1,07% |
| Penerbit tidak dikenal (CUSIP: 423494103) | $21.135.617 | 575.432 | 1,03% |
| Penerbit tidak dikenal (CUSIP: 698955101) | $15.820.626 | 578.028 | 0,77% |
| OMER | $6.832.925 | 718.499 | 0,33% |
| DFTX | $6.735.516 | 143.187 | 0,33% |
| Penerbit tidak dikenal (CUSIP: 60705V103) | $5.603.880 | 418.200 | 0,27% |
| TRVI | $4.849.000 | 260.000 | 0,24% |
| SYRE | $3.751.310 | 42.254 | 0,18% |
| NGEN | $2.488.956 | 1.208.231 | 0,12% |
| MDT | $2.417.307 | 30.900 | 0,12% |
| SGMT | $1.932.500 | 250.000 | 0,09% |
| CAPR | $1.792.708 | 74.448 | 0,09% |
| ALT | $1.433.254 | 471.465 | 0,07% |
| Penerbit tidak dikenal (CUSIP: 482931102) | $1.431.950 | 65.000 | 0,07% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| RVMD | Dipangkas | -104K | +$89.4M |
| TVTX | Beli lebih banyak | +701K | +$79.9M |
| LLY | Hanya pergerakan harga | +0 | +$27.6M |
| ARGX | Dipangkas | -46K | -$23.0M |
| MIRM | Dipangkas | -13K | +$18.5M |
| RYTM | Beli lebih banyak | +3K | +$16.9M |
| INSM | Beli lebih banyak | +48K | -$12.8M |
| UNH | Beli lebih banyak | +11K | +$12.2M |
| KYMR | Dipangkas | -44K | +$10.6M |
| BSX | Beli lebih banyak | +13K | -$9.8M |
2 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| EXAS | 31 Maret 2026 | 601.800 | $61.118.808 | Tidak lagi dilacak |
| MRUS | 31 Des. 2025 | 597.051 | $56.212.352 | Tidak lagi dilacak |
| FRPT | 31 Maret 2025 | 327.500 | $48.506.025 | -11,4% |
| CDTX | 31 Maret 2026 | 204.878 | $45.255.501 | Tidak lagi dilacak |
| ASND | 30 Juni 2026 | 194.000 | $44.373.620 | -3,3% |
| PODD | 31 Maret 2025 | 114.250 | $29.827.248 | -44,4% |
| AKRO | 31 Des. 2025 | 626.526 | $29.747.454 | Tidak lagi dilacak |
| BPMC | 30 Sep. 2025 | 185.500 | $23.777.390 | Tidak lagi dilacak |
| ACLX | 30 Juni 2026 | 169.859 | $19.503.210 | Tidak lagi dilacak |
| LFST | 31 Maret 2025 | 2.550.000 | $18.793.500 | 89,2% |
| LEGN | 30 Juni 2025 | 512.932 | $17.403.783 | -38,7% |
| UNH | 30 Sep. 2025 | 50.500 | $15.754.485 | 12,2% |
| WRBY | 30 Juni 2025 | 835.000 | $15.222.050 | 24,7% |
| CRNX | 31 Maret 2025 | 294.100 | $15.037.333 | 152,7% |
| OSCR | 30 Sep. 2025 | 700.000 | $15.008.000 | 62,8% |
| CNTA | 30 Juni 2026 | 351.828 | $13.974.608 | Tidak lagi dilacak |
| SWTX | 31 Maret 2025 | 328.911 | $11.883.554 | Tidak lagi dilacak |
| NMRA | 31 Maret 2025 | 955.106 | $10.124.124 | 55,5% |
| MREO | 31 Des. 2025 | 4.570.649 | $9.415.537 | -29,0% |
| XNCR | 31 Maret 2025 | 401.013 | $9.215.279 | 161,6% |
| SLNO | 30 Juni 2026 | 257.253 | $8.612.830 | Tidak lagi dilacak |
| REGN | 30 Juni 2026 | 10.100 | $7.803.664 | 34,4% |
| RAPT | 31 Maret 2026 | 213.731 | $7.239.069 | Tidak lagi dilacak |
| NUVL | 30 Sep. 2025 | 93.328 | $7.120.926 | Tidak lagi dilacak |
| APLS | 30 Juni 2026 | 162.750 | $6.547.433 | Tidak lagi dilacak |
| TERN | 30 Juni 2026 | 113.748 | $5.996.795 | Tidak lagi dilacak |
| CGEM | 30 Sep. 2025 | 668.233 | $5.031.794 | 266,9% |
| BHVN | 31 Maret 2025 | 129.858 | $4.850.196 | -40,7% |
| NVRO | 30 Juni 2025 | 800.494 | $4.674.885 | Tidak lagi dilacak |
| AGL | 31 Maret 2026 | 6.500.000 | $4.476.550 | 1088,0% |
| MRSN | 31 Maret 2026 | 152.586 | $4.414.313 | Tidak lagi dilacak |
| TBPH | 31 Maret 2026 | 208.771 | $3.906.105 | 4,5% |
| XBI | 30 Juni 2026 | 30.000 | $3.831.900 | Tidak lagi dilacak |
| CYPH | 31 Maret 2025 | 1.266.546 | $3.641.320 | 329,5% |
| KMTS | 30 Juni 2025 | 145.000 | $3.613.400 | 64,2% |
| ABOS | 31 Maret 2025 | 1.838.916 | $3.162.936 | 190,9% |
| INZY | 30 Juni 2025 | 3.445.299 | $3.135.222 | Tidak lagi dilacak |
| BEAM | 30 Juni 2025 | 150.020 | $2.929.891 | 71,5% |
| XLO | 31 Maret 2025 | 3.003.259 | $2.868.112 | 1160,4% |
| SGMT | 30 Juni 2025 | 787.808 | $2.568.254 | 34,3% |
| WST | 31 Des. 2025 | 9.750 | $2.557.718 | 28,2% |
| AUTL | 31 Maret 2025 | 1.032.988 | $2.427.522 | 59,4% |
| EW | 30 Juni 2026 | 28.900 | $2.314.312 | -1,2% |
| ACHC | 30 Juni 2026 | 75.500 | $1.765.945 | -9,3% |
| KRRO | 31 Des. 2025 | 35.719 | $1.710.583 | 66,5% |
| LUNG | 30 Sep. 2025 | 651.100 | $1.686.349 | 45,1% |
| BCRX | 30 Juni 2025 | 222.011 | $1.665.083 | 9,5% |
| CATX | 31 Des. 2025 | 444.383 | $1.524.234 | Tidak lagi dilacak |
| MGNX | 30 Juni 2025 | 1.145.214 | $1.454.422 | 245,0% |
| ALLK | 31 Maret 2025 | 1.100.409 | $1.331.495 | Tidak lagi dilacak |
| APLT | 31 Des. 2025 | 2.075.991 | $1.255.767 | Tidak lagi dilacak |
| IMVT | 31 Des. 2025 | 72.965 | $1.176.196 | 75,2% |
| SRPT | 30 Sep. 2025 | 68.600 | $1.173.060 | 1,5% |
| JAZZ | 30 Juni 2026 | 5.750 | $1.087.038 | 3,9% |
| VIGL | 30 Juni 2025 | 471.958 | $840.085 | Tidak lagi dilacak |
| PLRX | 30 Juni 2025 | 589.996 | $796.495 | -3,4% |
| SPRB | 30 Juni 2025 | 2.609.125 | $756.907 | -87,3% |
| BMEA | 31 Maret 2025 | 181.147 | $702.850 | -35,7% |
| KYTX | 31 Maret 2025 | 178.963 | $669.322 | 329,8% |
| ADAPY | 30 Sep. 2025 | 2.483.468 | $595.287 | Tidak lagi dilacak |
| GOSS | 30 Juni 2026 | 1.609.492 | $528.718 | -6,9% |
| CRL | 31 Des. 2025 | 2.700 | $422.442 | 45,5% |
| ETNB | 30 Sep. 2025 | 40.000 | $392.800 | Tidak lagi dilacak |
| NVAX | 31 Des. 2025 | 45.000 | $390.150 | 31,6% |
| FOLD | 30 Juni 2026 | 21.062 | $304.557 | Tidak lagi dilacak |
| PRTA | 31 Des. 2025 | 25.398 | $247.884 | -3,8% |
| VINC | 31 Maret 2025 | 891.719 | $234.344 | Tidak lagi dilacak |
| NUVBWS | 31 Maret 2026 | 134.028 | $44.229 | Tidak lagi dilacak |
| CGEN | 31 Des. 2025 | 13.430 | $19.742 | 75,2% |